Table 2. Patients' clinical characteristics.
Patient n° | Age | Sex | Histological type | Breslow score (mm) | Stade | Metastasis | Response | Survival (month) |
1 | 85 | Female | Desmoplastic | 4 | IIIC | Skin, lymph node | PR | 18† |
2 | 87 | Female | Mucosal | N/A | II (*) | PD | 6† | |
3 | 88 | Female | Lentigo maligna | 3,1 | IV M1b | Lung, Lymph node | SD | 21No treatment |
4 | 77 | Male | Lentigo maligna | 11 | IV M1b | Lung, skin | PD | 13† |
5 | 66 | Female | N/A | 2,6 | IIIC | Skin, lymph node | PD | 1Ipilimumab |
6 | 95 | Male | Superficial-spreading | 3,5 | IV M1b | Lung, skin, lymph node | PD | 3† |
7 | 62 | Male | Superficial-spreading | 1,1 | IV M1c | Lung, lymph node, liver, bone, thyroide | PD | 8† |
8 | 69 | Male | N/A | 3,5 | IV M1b | Lung | PD | 12Ipilimumab |
9 | 44 | Female | Superficial-spreading | 1,6 | IV M1c | Lung, lymph node, liver, brain | PD | 3† |
10 | 74 | Female | Acral-lentiginous | 2,4 | IIIC | Skin | SD | 9No treatment |
11 | 72 | Female | Superficial-spreading | 1,31 | IV M1a | Skin, lymph node | PD | 9† |
PD: progressive disease.
PR: partial response.
SD: stable disease.
: dead.
(*): Patient n°2 was inoperable, due to initial extension of its nasal tumor.